Shares of Chemed (NYSE:CHE) rose in after-market trading after the company reported Q4 results.
Earnings per share increased 21.56% over the past year to $5.13, which were in line with the estimate of $5.13.
Revenue of $533,289,000 rose by 2.10% year over year, which missed the estimate of $537,200,000.
The upcoming fiscal year's EPS expected to be between $17.00 ...
Full story available on Benzinga.com